Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EBM TechnologiesROCO:8409 +0.26%64 Return-on-Tangible-Equity is 34.59% as of Dec. 2025. GuruFocus rates ROCO:8409 with a GF Score™ of 64/100 and a GF Value™ of NT$25.62 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 576 Healthcare Providers & Services companies, EBM Technologies ranks worse than 68.58% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. EBM Technologies's annualized net income for the quarter that ended in Dec. 2025 was NT$105.4 Mil. EBM Technologies's average shareholder tangible equity for the quarter that ended in Dec. 2025 was NT$304.6 Mil. Therefore, EBM Technologies's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was 34.59%.
The historical rank and industry rank for EBM Technologies's Return-on-Tangible-Equity or its related term are showing as below:
ROCO:8409'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -14.65 Med: -4.53 Max: 2.65
Current: 2.65
During the past 13 years, EBM Technologies's highest Return-on-Tangible-Equity was 2.65%. The lowest was -14.65%. And the median was -4.53%.
ROCO:8409's Return-on-Tangible-Equity is ranked worse than 68.58% of 576
companies
in the Healthcare Providers & Services industry
Industry Median: 10.17
vs ROCO:8409: 2.65
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
EBM Technologies Return-on-Tangible-Equity Related Terms
EBM Technologies Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for EBM Technologies's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:8409 vs VEEV, BTSG, TEM: Return-on-Tangible-Equity Comparison
For the Health Information Services subindustry, EBM Technologies's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EBM Technologies Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, EBM Technologies's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where EBM Technologies's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 34.59% mean?
EBM Technologies (ROCO:8409) has a Return-on-Tangible-Equity of 34.59% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on EBM Technologies and its competitors. According to the industry distribution chart, EBM Technologies ranks #395 out of 576 companies in the Healthcare Providers & Services industry, placing it in the top 68.6%.
Is EBM Technologies' Return-on-Tangible-Equity too high?
EBM Technologies' current Return-on-Tangible-Equity is 34.59%. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.17. EBM Technologies' value of 34.59% is 240.1% above this industry median. Based on the distribution chart, EBM Technologies ranks #395 out of 576 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, EBM Technologies has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does EBM Technologies' Return-on-Tangible-Equity compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, EBM Technologies ranks #395 out of 576 companies for Return-on-Tangible-Equity. This places EBM Technologies in the lower half of its industry. The industry median Return-on-Tangible-Equity is 10.17. EBM Technologies' value of 34.59% is 240.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.17, based on 576 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EBM Technologies's current Return-on-Tangible-Equity of 34.59% is 240.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on EBM Technologies and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EBM Technologies's current Return-on-Tangible-Equity is 34.59%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EBM Technologies stock overvalued right now?
Based on GuruFocus' analysis, EBM Technologies (ROCO:8409) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$25.62, compared to a current price of NT$18.95 — trading 26% below its estimated fair value. The current Return-on-Tangible-Equity is 34.59% and 240.1% above the Healthcare Providers & Services industry median of 10.17. EBM Technologies' overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For EBM Technologies (ROCO:8409), the current Return-on-Tangible-Equity is 34.59% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EBM Technologies (ROCO:8409) Overvalued in 2026?
Based on GuruFocus' analysis, EBM Technologies stock appears to be undervalued.
The current stock price of NT$18.95 is trading 26% below its estimated GF Value™ of NT$25.62.
GuruFocus considers EBM Technologies to be Modestly Undervalued.
Key valuation signals for ROCO:8409:
Return-on-Tangible-Equity: 34.59%
GF Value™: NT$25.62 vs. price of NT$18.95 (26% below fair value)
Industry Position: 240.1% above the Healthcare Providers & Services median (#395 of 576)
No single metric tells the full story. See the ROCO:8409 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EBM Technologies Inc is engaged in picture archiving and communication systems. Its products include EBM diagnostic and reviewing station, EBM storage and utility server, and EBM breast imaging for PACS. The company develops and markets medical information technology solutions; and provides to the health sector.
64GF Score
Get the complete analysis for ROCO:8409
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:8409 has been successfully added to your 
